Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Anesthesiol. Jul 28, 2023; 12(1): 1-7
Published online Jul 28, 2023. doi: 10.5313/wja.v12.i1.1
Published online Jul 28, 2023. doi: 10.5313/wja.v12.i1.1
Malignant hyperthermia as a rare complication of local lidocaine injection: A case report
Mukosolu Florence Obi, Manveer Ubhi, Manjari Sharma, Frederick N Campos, Yash Garg, Department of Internal Medicine, Wyckoff Heights Medical Center, New York, NY 11237, United States
Vikhyath Namireddy, Chelsea Noel, Department of Medicine, St. Georges University School of Medicine, True Blue 38902, Grenada
Author contributions: Obi MF contributed to manuscript writing and editing, and data analysis; Namireddy V and Noel C contributed to data collection; Ubhi M, Garg Y, Sharma M, and Campos FN contributed to conceptualization and supervision; all authors read and approved the final manuscript.
Informed consent statement: Informed verbal consent was obtained from the patient for publication of this case report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Mukosolu Florence Obi, MD, Doctor, Department of Internal Medicine, Wyckoff Heights Medical Center, 374 Stockholm St, Brooklyn, New York, NY 11237, United States. omukosolu.florence@gmail.com
Received: April 29, 2023
Peer-review started: April 29, 2023
First decision: June 1, 2023
Revised: June 14, 2023
Accepted: July 3, 2023
Article in press: July 3, 2023
Published online: July 28, 2023
Processing time: 88 Days and 11.7 Hours
Peer-review started: April 29, 2023
First decision: June 1, 2023
Revised: June 14, 2023
Accepted: July 3, 2023
Article in press: July 3, 2023
Published online: July 28, 2023
Processing time: 88 Days and 11.7 Hours
Core Tip
Core Tip: Malignant hyperthermia is preventable in the clinical setting with the use of anesthetics like succinylcholine or inhaled versions like halothane or sevoflurane. Clinical findings like hypercarbia in the operating room or hyperthermia, tachycardia, muscle rigidity, and rhabdomyolysis are the sequela that follows. These symptoms rarely occur with the usage of local anesthetics like lidocaine. Given their wide application in the clinical setting, it is paramount for clinicians to be aware of the likelihood of malignant hyperthermia being caused by local anesthetics and to manage the symptoms as early as possible.